SurfWax News Index  |  Track News  |  Save/Exchange Information |  WikiWax |  About Us

    News and Articles on SIGA Technologies (SIGA)


      CBS Marketwatch
    Quote
    Chart
    Yahoo! Finance:
    Profile
    Key Statistics
    SEC Filings
    MSN Money
    Earnings Estimates
    Financial Results
    Insider Trading
     

    Semi-Annual Changes to the NASDAQ Biotechnology Index  Nov 14, 2009
    China Sky One Medical, Inc. (Nasdaq: - ), Hi-Tech Pharmacal Co., Inc. (Nasdaq: - ), Poniard Pharmaceuticals, Inc. (Nasdaq: - ), SIGA Technologies, Inc. (Nasdaq: - ), Spectrum Pharmaceuticals, Inc. (Nasdaq: - ), Targacept, Inc. (Nasdaq: - ), Vical Incorporated (Nasdaq: - ), and Vanda Pharmaceuticals Inc. (Nasdaq: - ). All securities are classified according to the Industry Classification Benchmark (ICB) as either biotechnology or pharmaceutical. (Primezone Releases)

    Drug developed in Corvallis lab stands ready to fight smallpox  Mar 11, 2009
    Siga Technologies Inc. in Corvallis is a beneficiary of that fear. Siga's search for an antiviral smallpox drug started before 2001, but Sept. 11 accelerated its work and opened the federal spigot for research and development to counter biological warfare. (OregonLive, OR -- News)

    SIGA Technologies to Discuss Year-End 2008 Results of Operations On March 12, 2009  Mar 10, 2009
    Source: SIGA Technologies, Inc. ... NEW YORK, March 9, 2009 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (NasdaqCM: - ), a company specializing in the development of pharmaceutical agents to fight bio-warfare pathogens, plans to discuss its year-end 2008 results in a press release that will be issued on Thursday, March 12, 2009 before the market open ... Participants should call 877-741-4248 (United States/Canada) or 719-325-4750 (International) and request the SIGA Technologies call or utilize... (Primezone Releases)

    ST-246(r) in Combination With the Smallpox Vaccine ACAM2000(tm) Confers Protective Immunity in Primates  Feb 24, 2009
    Source: SIGA Technologies, Inc. ... NEW YORK, Feb. 24, 2009 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (NasdaqCM: - ), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, today announced the results of a non-human primate study by the Southern Research Institute (SRI) that suggests that ST-246(r) can be used in combination with a well-known smallpox vaccine and may improve the safety profile of the vaccine ... About SIGA Technologies, Inc.. (Primezone Releases)




    Back to Company News News

[ Terms Of Use | Privacy | About ]
©1998-2006 SurfWax, Inc.
All rights reserved. Patents pending.



Copyright SurfWax, Inc. 2006